Perhaps a benchmark of excess mortality with Tanzania and Bulgaria, with << treatment would come in handy. Or, a multi country data analysis of the treatment rollout percentage, vs excess mortality may yield a correlation?
What are we to make of these much lower than flu deaths prior to injections to much higher than flu post injections? Cause of death data would reveal plenty.
Perhaps a benchmark of excess mortality with Tanzania and Bulgaria, with << treatment would come in handy. Or, a multi country data analysis of the treatment rollout percentage, vs excess mortality may yield a correlation?
Chris, in the follow-up report I posted on this topic [ https://deepd1ve.substack.com/p/top-nation-for-mrna-uptake-pt-2 ], an effect can be viewed with the naked eye using Japan as their own control.
The nice thing about using yourself as your own control is that it eliminates almost all potential confounders and almost all bias.
What are we to make of these much lower than flu deaths prior to injections to much higher than flu post injections? Cause of death data would reveal plenty.